Prevalence of gBRCA1/2 mutations stratified by (A) FIGO stage, and (B) family history of cancer. Prevalence of gBRCA1/2 mutations stratified by (A) FIGO stage, and (B) family history of cancer. In panel (A), three patients with a FIGO stage of ‘other’ were not included in the analysis. FIGO, International Federation of Gynecology and Obstetrics; gBRCA, germline BRCA. Takayuki Enomoto et al. Int J Gynecol Cancer 2019;29:1043-1049 © IGCS and ESGO 2019. Re-use permitted under CC BY. Published by BMJ.